Published in Am J Trop Med Hyg on March 01, 1978
Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis (2010) 1.18
Dynamic analysis of splenic Th1 and Th2 lymphocyte functions in mice infected with Schistosoma japonicum. Infect Immun (1991) 1.05
Depressed in vitro and in vivo antibody response and adoptive transfer of delayed hypersensitivity to myoglobin with spleen cells of mice chronically infected with Schistosoma japonicum and injected with myoglobin. Infect Immun (1984) 0.91
Eosinophil chemotactic lymphokine produced by egg-associated granulomas in murine schistosomiasis japonicum. Infect Immun (1986) 0.83
Characterization of the glycoprotein antigens which mediate the Schistosoma japonicum circumoval precipitin reaction. Infect Immun (1981) 0.82
Immunization against Schistosoma mansoni in rhesus monkeys and the requirement of activation of both cell-mediated and humoral mechanisms. Infect Immun (1979) 0.81
Potentiation of schistosome granuloma formation. By lentinan--a T-cell adjuvant. Am J Pathol (1979) 0.80
Granulocyte-macrophage colony-stimulating factor produced by splenic T lymphocytes of mice infected with Schistosoma japonicum. Infect Immun (1986) 0.79
Schistosoma japonicum soluble egg antigens attenuate IFN-γ-induced MHC class II expression in RAW 264.7 macrophages. PLoS One (2012) 0.78
Fractionation of Schistosoma japonicum soluble egg antigen glycoproteins by hydrophobic interaction chromatography. Infect Immun (1981) 0.77
Reduction of contact sensitivity reactions to oxazolone in mite-infested mice. Infect Immun (1979) 0.76
Schistosoma mekongi infection in man: cellular immune responses and modulating mechanisms. Clin Exp Immunol (1982) 0.75
Inhibition of immediate and Arthus responses to schistosome egg antigens by T cells from Schistosoma japonicum-infected mice. Infect Immun (1986) 0.75
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
Strongyloidiasis in Allied ex-prisoners of war in south-east Asia. Br Med J (1980) 2.56
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18
Delay in appropriate therapy of Legionella pneumonia associated with increased mortality. Eur J Clin Microbiol Infect Dis (1996) 2.14
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
Failed prophylactic zidovudine after needlestick injury. Lancet (1990) 2.00
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84
Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis. Nature (1978) 1.65
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56
Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47
Secretory IgA against enterotoxins in breast-milk. Lancet (1976) 1.47
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44
An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37
Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34
The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs. Am J Trop Med Hyg (1967) 1.33
Th ecology of the medical literatures. Am J Med Sci (1972) 1.32
Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol (1997) 1.31
Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med Med Econ (1980) 1.31
Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A (1997) 1.30
Experimental infection of humans with Ancylostoma ceylanicum: clinical, parasitological, haematological and immunological findings. Trop Geogr Med (1986) 1.29
The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol (1977) 1.29
Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29
The secretion of migration inhibitory factor by intact schistosome egg granulomas maintained in vitro. Nature (1973) 1.28
Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27
Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis (1977) 1.25
Increased incidence of hepatoma in mice with chronic schistosomiasis mansoni treated with a carcinogen. Am J Pathol (1967) 1.23
Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci U S A (2005) 1.21
Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis. J Infect Dis (1975) 1.21
Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. J Immunol (1976) 1.21
Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ (1976) 1.19
Diagnosis of human strongyloidiasis by immunofluorescence, using Strongyloides ratti and S. stercoralis larvae. Am J Trop Med Hyg (1981) 1.19
Morbidity in Schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg (1976) 1.19
Rapid, accurate quantification of schistosome eggs via nuclepore filters. J Parasitol (1976) 1.18
Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18
Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature (1976) 1.16
Antieosinophil serum and the kinetics of eosinophilia in Schistosomiasis mansoni. J Exp Med (1975) 1.15
Concanavalin A-induced release of skin-reactive factor from lymphoid cells. J Immunol (1970) 1.15
Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay. Trans R Soc Trop Med Hyg (1981) 1.13
Treatment of strongyloidiasis with thiabendazole: an analysis of toxicity and effectiveness. Trans R Soc Trop Med Hyg (1982) 1.12
Schistosomiasis haematobia in coast province Kenya. Relationship between egg output and morbidity. Am J Trop Med Hyg (1979) 1.11
Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils. J Exp Med (1973) 1.11
Liver collagen synthesis in murine schistosomiasis. J Clin Invest (1977) 1.11
The humanities in medical education. Ann Intern Med (1984) 1.11
Morbidity in relation to intensity of infection in Opisthorchiasis viverrini: study of a community in Khon Kaen, Thailand. Am J Trop Med Hyg (1982) 1.10
Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer. Genes Chromosomes Cancer (2008) 1.10
Serological diagnosis of bancroftian and malayan filariasis. Am J Trop Med Hyg (1978) 1.10
The bentonite granuloma. Characterization of a model system for infectious and foreign body granulomatous inflammation using soluble mycobacterial, histoplasma and schistosoma antigens. Immunology (1973) 1.10
Inhibition of granuloma formation around Schistosoma mansoni eggs. IV. X-irradiation. Am J Pathol (1969) 1.09
Biocompatibility of silicone implants. Ann Plast Surg (1983) 1.09
An ultrastructural study of hepatic granulomas and schistosome egg shells in murine hepatosplenic schistosomiasis mansoni. Exp Mol Pathol (1967) 1.08
Humoral and cellular immunity in asthma. J Allergy Clin Immunol (1975) 1.08
Humoral and cellular immunity in atopic eczema. Br J Dermatol (1975) 1.07
New scientific opportunities and old obstacles in vaccine development. Proc Natl Acad Sci U S A (1986) 1.06
Inheritance of mixed cryoglobulinemia. Am J Hum Genet (1981) 1.06
Algorithms in the diagnosis and management of exotic diseases. xxii. ascariasis and toxocariasis. J Infect Dis (1977) 1.06
Purified antigen radioimmunoassay in serological diagnosis of schistosomiasis mansoni. Lancet (1977) 1.04
In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory responses. J Immunol (1974) 1.03
The lymphokine eosinophil stimulation promoter and human schistosomiasis mansoni. J Infect Dis (1975) 1.03
Cercariae of Schistosoma mansoni and plants: attempt to penetrate Phaseolus vulgaris and Hedychium coronarium produces a cercaricide. Nature (1968) 1.03
Specific granulomatous hypersensitivity elicited by bentonite particles coated with soluble antigens from schistosome eggs and turcle bacilli. Nature (1971) 1.02
A controlled study of morbidity of schistosomiasis mansoni in St. Lucian children, based on quantitative egg excretion. Am J Trop Med Hyg (1974) 1.02
The secret of the immunopathogenesis of schistosomiasis: in vivo models. Immunol Rev (1982) 1.02
Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis (1982) 1.02
Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni. J Immunol (1980) 1.01
The Schistosoma japonicum egg granuloma. Am J Pathol (1975) 1.01
Induction of granulomatous and elicitation of cutaneous sensitivity by partially purified SEA of Schistosoma mansoni. J Immunol (1977) 1.01
Vertebral osteomyelitis due to Staphylococcus warneri. Ann Rheum Dis (1986) 0.99
Immunodiagnosis of infection with Schistosoma mansoni: comparison of ELISA, radioimmunoassay, and precipitation tests performed with antigens from eggs. Am J Trop Med Hyg (1979) 0.99
In vivo microscopic observations of the pathogenesis and pathophysiology of hepatosplenic schistosomiasis in the mouse liver. Am J Trop Med Hyg (1972) 0.99
The eosinophil stimulation promoter test in murine and human Trichinella spiralis infection. J Infect Dis (1976) 0.98
Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians (1976) 0.98
Immunoregulation in chronic infectious disease: schistosomiasis as a model. J Invest Dermatol (1978) 0.98